Ubiquitin C‐terminal hydrolase L1 after out‐of‐hospital cardiac arrest

We studied the prognostic ability of serum ubiquitin C‐terminal hydrolase L1 (UCH‐L1) after out‐of‐hospital cardiac arrest (OHCA), compared to that of neuron‐specific enolase (NSE).

[1]  J. Soar,et al.  Prediction of good neurological outcome in comatose survivors of cardiac arrest: a systematic review , 2022, Intensive Care Medicine.

[2]  R. Latini,et al.  Neurofilament light compared to neuron-specific enolase as a predictor of unfavourable outcome after out-of-hospital cardiac arrest. , 2022, Resuscitation.

[3]  C. Fordyce,et al.  Neurologic Prognostication After Cardiac Arrest Using Brain Biomarkers: A Systematic Review and Meta-analysis. , 2022, JAMA neurology.

[4]  G. Beligere,et al.  Evaluation of Acute Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Plasma Levels in Traumatic Brain Injury Patients with and without Intracranial Lesions , 2021, Neurotrauma reports.

[5]  T. Cronberg,et al.  Brain injury after cardiac arrest: pathophysiology, treatment, and prognosis , 2021, Intensive Care Medicine.

[6]  N. Nielsen,et al.  Neuron-Specific Enolase and long-term neurological outcome after OHCA - a validation study. , 2021, Resuscitation.

[7]  K. Blennow,et al.  Serum markers of brain injury can predict good neurological outcome after out-of-hospital cardiac arrest , 2021, Intensive Care Medicine.

[8]  Kevin K. W. Wang,et al.  Ultra-early serum concentrations of neuronal and astroglial biomarkers predict poor neurological outcome after out-of-hospital cardiac arrest—a pilot neuroprognostic study☆ , 2021, Resuscitation plus.

[9]  J. Soar,et al.  European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care , 2021, Intensive Care Medicine.

[10]  N. Lundbom,et al.  Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial , 2020, Intensive Care Medicine.

[11]  C. Hassager,et al.  Performance of a guideline-recommended algorithm for prognostication of poor neurological outcome after cardiac arrest , 2020, Intensive Care Medicine.

[12]  M. Wise,et al.  Serum GFAP and UCH-L1 for the prediction of neurological outcome in comatose cardiac arrest patients. , 2020, Resuscitation.

[13]  Lars Etholm,et al.  Late awakening, prognostic factors and long-term outcome in out-of-hospital cardiac arrest - results of the prospective Norwegian Cardio-respiratory Arrest Study (NORCAST). , 2020, Resuscitation.

[14]  V. Pettilä,et al.  Usefulness of neuron specific enolase in prognostication after cardiac arrest: Impact of age and time to ROSC. , 2019, Resuscitation.

[15]  D. Kent,et al.  Early withdrawal of life support after resuscitation from cardiac arrest is common and may result in additional deaths. , 2019, Resuscitation.

[16]  Philip S. Insel,et al.  Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest , 2019, JAMA neurology.

[17]  C. Callaway,et al.  The present and future of cardiac arrest care: international experts reach out to caregivers and healthcare authorities , 2018, Intensive Care Medicine.

[18]  I. Nordrum,et al.  Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation , 2017, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  C. Ploner,et al.  Neuron-Specific Enolase Predicts Poor Outcome After Cardiac Arrest and Targeted Temperature Management: A Multicenter Study on 1,053 Patients , 2017, Critical care medicine.

[20]  M. Wise,et al.  Neuron-Speci fi c Enolase as a Predictor of Death or Poor Neurological Outcome After Out-of-Hospital Cardiac Arrest and Targeted Temperature Management at 33 C and 36 C , 2015 .

[21]  R. Hayes,et al.  UCH-L1 and GFAP Serum Levels in Neonates with Hypoxic–Ischemic Encephalopathy: A Single Center Pilot Study , 2014, Front. Neurol..

[22]  T. Cronberg,et al.  Prognostication after cardiac arrest. , 2013, Best practice & research. Clinical anaesthesiology.

[23]  E. Ruokonen,et al.  Therapeutic hypothermia after out-of-hospital cardiac arrest in Finnish intensive care units: the FINNRESUSCI study , 2013, Intensive Care Medicine.

[24]  A. Gabrielli,et al.  Clinical Utility of Serum Levels of Ubiquitin C-terminal Hydrolase as a Biomarker for Severe Traumatic Brain Injury , 2022 .

[25]  W. Baumgartner,et al.  Serum levels of neuron-specific ubiquitin carboxyl-terminal esterase-L1 predict brain injury in a canine model of hypothermic circulatory arrest. , 2011, The Journal of thoracic and cardiovascular surgery.

[26]  A. Gabrielli,et al.  Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. , 2011, Journal of neurotrauma.

[27]  T. Deufel,et al.  Serum concentration of NSE and S-100b during LVAD in non-resuscitated patients. , 2008, Resuscitation.

[28]  T. Zima,et al.  Performance Characteristics of Seven Neuron-Specific Enolase Assays , 2007, Tumor Biology.

[29]  J. Nolan,et al.  Mode of death after admission to an intensive care unit following cardiac arrest , 2004, Intensive Care Medicine.

[30]  H. Reiber,et al.  Neuron‐Specific Enolase Concentrations in Blood as a Prognostic Parameter in Cerebrovascular Diseases , 1994, Stroke.

[31]  S. Mckinstry,et al.  Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction , 1991, European journal of clinical investigation.

[32]  J. Bergh,et al.  Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung. , 1985, Thorax.

[33]  R. Thompson,et al.  Isolation of PGP 9.5, a New Human Neurone‐Specific Protein Detected by High‐Resolution Two‐Dimensional Electrophoresis , 1983, Journal of neurochemistry.

[34]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[35]  P. Jackson,et al.  The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis , 1981, Journal of the Neurological Sciences.

[36]  P. Urdal,et al.  Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage , 2005, Acta Neurochirurgica.

[37]  B Jennett,et al.  Assessment of outcome after severe brain damage. , 1975, Lancet.

[38]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.